Published in J Pediatr on August 01, 1997
Treatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin B: randomised trial. BMJ (2001) 1.50
Clinical and experimental advances in treatment of visceral leishmaniasis. Antimicrob Agents Chemother (2001) 1.39
Liposomal amphotericin B as a treatment for human leishmaniasis. Expert Opin Emerg Drugs (2012) 1.24
Liposomal amphotericin B and leishmaniasis: dose and response. J Glob Infect Dis (2010) 0.92
Efficacious treatment of experimental leishmaniasis with amphotericin B-arabinogalactan water-soluble derivatives. Antimicrob Agents Chemother (1999) 0.89
Species-directed therapy for leishmaniasis in returning travellers: a comprehensive guide. PLoS Negl Trop Dis (2014) 0.88
Pediatric Visceral Leishmaniasis Caused by Leishmania infantum in Northern Cyprus. Am J Trop Med Hyg (2016) 0.84
Efficacious topical treatment for murine cutaneous leishmaniasis with ethanolic formulations of amphotericin B. Antimicrob Agents Chemother (1998) 0.82
Visceral leishmaniasis and haemophagocytic syndrome in an Omani child. J Sci Res Med Sci (2002) 0.75
Visceral Leishmaniasis as a Possible Reason for Pancytopenia. Front Pediatr (2015) 0.75
Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study. Lancet (2000) 7.25
Immunological phenomena in leprosy and related diseases. Adv Immunol (1971) 5.55
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect (2012) 4.56
Immunity in cutaneous leishmaniasis of the guinea-pig. Clin Exp Immunol (1970) 4.50
Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment. J Immunol (2001) 3.79
Immunosuppression in children with malaria. Lancet (1972) 3.11
Diffuse cutaneous leishmaniasis in Ethiopia. I. The clinical and histological features of the disease. Trans R Soc Trop Med Hyg (1969) 2.78
Allergic complications of meningococcal disease. II. Immunological investigations. Br Med J (1973) 2.61
Quantitation of amastigotes of Leishmania donovani in smears of splenic aspirates from patients with visceral leishmaniasis. Am J Trop Med Hyg (1983) 2.57
Malaria at Christmas: risks of prophylaxis versus risks of malaria. BMJ (1998) 2.48
Severity of imported falciparum malaria: effect of taking antimalarial prophylaxis. BMJ (1992) 2.36
Fever as the presenting complaint of travellers returning from the tropics. QJM (1995) 2.34
Diffuse cutaneous leishmaniasis in Ethiopia. 3. Immunological studies. IV. Pathogenesis of diffuse cutaneous leishmaniasis. Trans R Soc Trop Med Hyg (1970) 2.32
Phlebotomine sandflies and the spreading of leishmaniases and other diseases of public health concern. Med Vet Entomol (2012) 2.31
Lesions of schistosomiasis mimicking warts on the vulva. BMJ (1993) 2.25
Allertic complications of meningococcal disease. I. Clinical aspects. Br Med J (1973) 2.20
Experimental cutaneous leishmaniasis. II. Effects of immunosuppression and antigenic competition on the course of infection with Leishmania enriettii in the guinea-pig. Clin Exp Immunol (1972) 2.15
Disappearance of immunoglobulin and complement from the Arthus reaction and its relevance to studies of vasculitis in man. Br J Dermatol (1971) 2.11
Association between antifungal prophylaxis and rate of documented bacteremia in febrile neutropenic cancer patients. Clin Infect Dis (2001) 2.03
Immunosuppression in Kenyan visceral leishmaniasis. Clin Exp Immunol (1983) 2.00
Adverse reactions in expatriates treated with ivermectin. Lancet (1990) 1.98
Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1beta on tuberculosis. J Exp Med (1999) 1.97
Cell-mediated immunity during natural measles infection. J Clin Invest (1978) 1.93
Liposomal amphotericin B in drug-resistant visceral leishmaniasis. Lancet (1991) 1.87
Prevalence and associations of vitamin D deficiency in foreign-born persons with tuberculosis in London. J Infect (2005) 1.87
A retrospective clinical study of canine leishmaniasis in 150 dogs naturally infected by Leishmania infantum. Vet Rec (1997) 1.86
Pulmonary tuberculosis among political asylum seekers screened at Heathrow Airport, London, 1995-9. Thorax (2002) 1.84
Relapse of visceral leishmaniasis in patients who were coinfected with human immunodeficiency virus and who received treatment with liposomal amphotericin B. Clin Infect Dis (1994) 1.79
Central venous catheter-related complications in children with oncological/hematological diseases: an observational study of 418 devices. Ann Oncol (2005) 1.77
Short-course treatment of visceral leishmaniasis with liposomal amphotericin B (AmBisome). Clin Infect Dis (1996) 1.75
Mice transgenic for human CD4 and CCR5 are susceptible to HIV infection. Proc Natl Acad Sci U S A (1997) 1.74
Ethiopian visceral leishmaniasis: generic and proprietary sodium stibogluconate are equivalent; HIV co-infected patients have a poor outcome. Trans R Soc Trop Med Hyg (2002) 1.69
The effect of prolonged treatment with antilymphocyte serum on the course of infections with BCG and Leishmania enriettii in the guinea-pig. J Pathol (1971) 1.66
Severe falciparum malaria: predicting the effect of exchange transfusion. QJM (1994) 1.65
Hepatitis C virus infection and related liver disease in children of mothers with antibodies to the virus. J Pediatr (1997) 1.64
Practical progress and new drugs for changing patterns of leishmaniasis. Parasitol Today (1993) 1.64
Visceral leishmaniasis in HIV infection and AIDS: clinical features and response to therapy. Q J Med (1990) 1.61
Efficacy and safety of liposomal amphotericin B (AmBisome) for visceral leishmaniasis in endemic developing countries. Bull World Health Organ (1998) 1.60
Clinical pathology of the Jarisch-Herxheimer reaction. J Infect Dis (1976) 1.56
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT). Clin Microbiol Infect (2012) 1.55
Posttransfusion and community-acquired hepatitis C in childhood. J Pediatr Gastroenterol Nutr (1994) 1.55
Lymphocyte mitogenic factor in man. Nature (1969) 1.51
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp. Clin Microbiol Infect (2012) 1.48
Dermonodular and visceral leishmaniasis due to Leishmania infantum with a new isoenzyme pattern: report of a case involving a patient with AIDS. Clin Infect Dis (1996) 1.47
Louse-borne relapsing fever. Q J Med (1970) 1.46
Liposomal amphotericin B (AmBisome) in Mediterranean visceral leishmaniasis: a multi-centre trial. Q J Med (1994) 1.46
Epidemiological surveillance of leishmaniasis in HIV-1-infected individuals in Italy. AIDS (1996) 1.46
Comparison of two dosage schedules of sodium stibogluconate in the treatment of visceral leishmaniasis in Kenya. Lancet (1983) 1.45
A cloned antigen (recombinant K39) of Leishmania chagasi diagnostic for visceral leishmaniasis in human immunodeficiency virus type 1 patients and a prognostic indicator for monitoring patients undergoing drug therapy. J Infect Dis (1998) 1.43
Subacute pulmonary granulomatous schistosomiasis: high resolution CT appearances--another cause of the halo sign. Br J Radiol (2001) 1.43
Mineralocorticoid deficiency in HIV infection. BMJ (1989) 1.43
Haemophagocytic syndrome in rheumatic patients. A systematic review. Eur Rev Med Pharmacol Sci (2012) 1.42
Decreased sensitivity to meglumine antimoniate (Glucantime) of Leishmania infantum isolated from dogs after several courses of drug treatment. Ann Trop Med Parasitol (1992) 1.41
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures. Clin Microbiol Infect (2012) 1.41
Italy versus the United Kingdom: differing styles for treating bacteremia in the critically ill patient, but who's right? Minerva Anestesiol (2008) 1.39
Group G streptococcal endocarditis: two case reports, a review of the literature and recommendations for treatment. J Infect (1988) 1.35
Evidence for an impact on the incidence of canine leishmaniasis by the mass use of deltamethrin-impregnated dog collars in southern Italy. Med Vet Entomol (2001) 1.33
Tuberculosis diagnosed during pregnancy: a prospective study from London. Thorax (2000) 1.32
Visceral leishmaniasis unresponsive to antimonial drugs. III. Successful treatment using a combination of sodium stibogluconate plus allopurinol. Trans R Soc Trop Med Hyg (1985) 1.31
Association between Gc genotype and susceptibility to TB is dependent on vitamin D status. Eur Respir J (2009) 1.30
Under-reporting of malaria, a notifiable disease, in Britain. J Infect (1993) 1.29
Epidemic visceral leishmaniasis in Sudan: a randomized trial of aminosidine plus sodium stibogluconate versus sodium stibogluconate alone. J Infect Dis (1993) 1.29
Evaluation of the Leishmania recombinant K39 antigen as a diagnostic marker for canine leishmaniasis and validation of a standardized enzyme-linked immunosorbent assay. Vet Parasitol (2002) 1.28
A comparison of three dosage regimens of sodium stibogluconate in the treatment of visceral leishmaniasis in Kenya. J Infect Dis (1983) 1.28
Visceral leishmaniasis unresponsive to antimonial drugs. II. Response to high dosage sodium stibogluconate or prolonged treatment with pentamidine. Trans R Soc Trop Med Hyg (1985) 1.26
Schistosomiasis in expatriates returning to Britain from the tropics: a controlled study. Lancet (1986) 1.26
Central venous catheter-related infection due to Comamonas acidovorans in a child with non-Hodgkin's lymphoma. Clin Infect Dis (1994) 1.26
Studies of the mechanism of the Jarisch-Herxheimer reaction in louse-borne relapsing fever: evidence for the presence of circulating Borrelia endotoxin. Clin Sci (1972) 1.25
Rapid diagnosis of Falciparum malaria by using the ParaSight F test in travellers returning to the United Kingdom: prospective study. BMJ (2000) 1.25
Liposomal amphotericin B in the treatment of visceral leishmaniasis. J Antimicrob Chemother (1991) 1.24
Diffuse cutaneous leishmaniasis in Ethiopia. II. Treatment. Trans R Soc Trop Med Hyg (1970) 1.23
Risk factors for extended-spectrum beta-lactamase-producing Serratia marcescens and Klebsiella pneumoniae acquisition in a neonatal intensive care unit. J Hosp Infect (2007) 1.23
Distribution of VP7 serotypes and VP4 genotypes among rotavirus strains recovered from Italian children with diarrhea. Arch Virol (1997) 1.23
Disseminated human immunodeficiency virus 1 (HIV-1) infection in SCID-hu mice after peripheral inoculation with HIV-1. J Exp Med (1994) 1.22
Immunological aspects of clinical leishmaniasis. Proc R Soc Med (1970) 1.20
Visceral leishmaniasis in HIV infected patients: treatment with high dose liposomal amphotericin B (AmBisome). J Infect (1996) 1.19
Emergence or re-emergence of visceral leishmaniasis in areas of Somalia, north-eastern Kenya, and south-eastern Ethiopia in 2000-01. Trans R Soc Trop Med Hyg (2004) 1.19
Divergent effects of chronic HIV-1 infection on human thymocyte maturation in SCID-hu mice. J Immunol (1995) 1.18
Role of PCR in diagnosis and prognosis of visceral leishmaniasis in patients coinfected with human immunodeficiency virus type 1. J Clin Microbiol (2001) 1.18
Murine dendritic cells internalize Leishmania major promastigotes, produce IL-12 p40 and stimulate primary T cell proliferation in vitro. Eur J Immunol (1999) 1.17
Chronic hepatitis C in children: the pathological and clinical spectrum. Gastroenterology (1998) 1.17
Studies on canine leishmaniasis control. 1. Evolution of infection of different clinical forms of canine leishmaniasis following antimonial treatment. Trans R Soc Trop Med Hyg (1988) 1.17